| http://www.w3.org/ns/prov#value | - variants and methods for their generationEP2050335A1Feb 9, 2007Apr 22, 2009Genentech, Inc.Gene disruptions, compositions and methods relating theretoEP2052742A1Jun 14, 2001Apr 29, 2009Biogen Idec Inc.Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combinationEP2055313A1Nov 9, 1999May 6, 2009Biogen
|
